Do you identify as LGBTQ+ and experience strong emotion? Want to learn some effective coping skills? Help us explore and understand the mental health experiences of the LGBTQ+ community, and how coping skills can help. This study is created by an LGBTQ+ researcher for the...
This is a multicenter longitudinal study that aims to validate a set of measures that were previously identified as promising candidate biomarkers and/or sensitive and reliable objective measures of social function in ASD for potential use in clinical trials. The confirmation study will repeat the...
This study tests the efficacy of a group Cognitive Behavioral Therapy designed to be “transdiagnostic” (applying to a wide range of anxiety and mood problems). This treatment has been shown to reduce negative emotions such as anxiety and depression in an individual therapy format. We...
This study is completely online and via smartphone and will last 6 weeks. All participants will receive a digital (app-based) treatment for anxiety and worry and will be asked to use the app for 6-weeks. The study will also involve completing 3 phone calls with a study...
To evaluate the efficacy of troriluzole as adjunctive therapy compared to placebo in subjects with OCD who have had an inadequate response to their current OCD treatment based on the change in their Y-BOCS score To assess the safety and tolerability of troriluzole, relative to placebo,...
To evaluate the efficacy, safety, and tolerability of AVP-786 compared to placebo, for the treatment of agitation in patients with dementia of the Alzheimer's type To evaluate the effects of AVP-786 compared to placebo on neuropsychiatric symptoms To evaluate the effects of AVP-786 compared to placebo on...
To evaluate the clinical efficacy of ATH-1017 To determine the safety and tolerability of ATH-1017 To evaluate the clinical efficacy of ATH-1017 separately on: (1) cognition and (2) clinical global impression of change To evaluate the effect of ATH-1017 on activities of daily living To determine the plasma pharmacokinetic (PK) profile...
To determine if treatment with SAGE-217 reduces depressive symptoms in women with postpartum depression (PPD) compared to placebo. To determine if treatment with SAGE-217 reduces anxiety symptoms compared to placebo. To assess self-report of depressive symptoms To evaluate the safety and tolerability of SAGE-217 This is a PHASE 3...
This research study is a collaboration between the University of Wyoming and the University of Washington. We are asking you to complete this survey because you are over the age of 65 years. The purpose of this survey is to better understand various health behaviors and...
The University of Washington is conducting a research study called Do More Feel Better for adults aged 60 and older who attend senior centers and are experiencing depression. The program is based on research showing that increasing your participation in pleasurable and rewarding activities can...
